Thursday, June 11, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 100 of 1,261
  1. US 12064502

    Peptide exhibiting wrinkle-improving activity and uses thereof

    CAREGEN CO., LTD. Β· Granted Aug 20, 2024 Β· Expires Aug 15, 2044

    granted
  2. US 12064516

    Pharmaceutical formulations and uses thereof

    Aldeyra Therapeutics, Inc. Β· Granted Aug 20, 2024 Β· Expires Aug 15, 2044

    granted
  3. US 12065490

    Chimeric antigen receptors and methods of making

    The Board of Regents of the University of Texas System Β· Granted Aug 20, 2024 Β· Expires Aug 15, 2044

    granted
  4. US 12064453

    Biochemical and biomechanical conditioning for enhancing personalized mesenchymal stem cell therapies

    The Board of Regents of the University of Texas System Β· Granted Aug 20, 2024 Β· Expires Aug 15, 2044

    granted
  5. US 12064433

    Pyridone A2R antagonists

    Arcus Biosciences, Inc. Β· Granted Aug 20, 2024 Β· Expires Aug 15, 2044

    granted
  6. US 12064398

    Parenteral formulations

    JAZZ PHARMACEUTICALS RESEARCH UK LIMITED Β· Granted Aug 20, 2024 Β· Expires Aug 15, 2044

    granted
  7. US 12065479

    Force sensor cleavage domain containing chimeric polypeptides and methods of use thereof

    The Regents of the University of California Β· Granted Aug 20, 2024 Β· Expires Aug 15, 2044

    granted
  8. US 12064512

    Silyl lipids suitable for enhanced delivery of anti-viral therapeutics

    The Regents of the University of California Β· Granted Aug 20, 2024 Β· Expires Aug 15, 2044

    granted
  9. UY 40646

    DERIVADOS DE N-Γ“XIDO DE ETIL-SULFONA/SULFOXIMINA-PIRIDINA SUSTITUIDOS CON CICLOPROPIL-(HETERO)ARILO

    BOEHRINGER INGELHEIM VETMEDICA GMBH [DE] Β· Granted Aug 15, 2024 Β· Expires Aug 10, 2044

    granted
  10. UY 40645

    DERIVADOS DE ETIL-SULFOXIMA-PIRIDINA SUSTITUIDOS CON CICLOPROPIL-(HETERO)ARILO

    BOEHRINGER INGELHEIM VETMEDICA GMBH [DE] Β· Granted Aug 15, 2024 Β· Expires Aug 10, 2044

    granted
  11. UY 40647

    DERIVADOS DE ETILSULFONA/SULFOXIMINA-PIRIDINA SUSTITUIDOS CON TETRAZOL

    BOEHRINGER INGELHEIM VETMEDICA GMBH [DE] Β· Granted Aug 15, 2024 Β· Expires Aug 10, 2044

    granted
  12. US 12059413

    Methods of inhibiting viruses using compositions targeting TSG101-ubiquitin interaction

    The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Aug 13, 2024 Β· Expires Aug 8, 2044

    granted
  13. US 12059474

    Methods for selecting antibodies that specifically bind glycosylated immune checkpoint proteins

    The Board of Regents of the University of Texas System Β· Granted Aug 13, 2024 Β· Expires Aug 8, 2044

    granted
  14. US 12059437

    Methods and compositions for hematopoietic stem cell mobilization

    The Regents of the University of California Β· Granted Aug 13, 2024 Β· Expires Aug 8, 2044

    granted
  15. US 12059400

    Medical compound

    VERA SALUS RICERCA S.R.L. Β· Granted Aug 13, 2024 Β· Expires Aug 8, 2044

    granted
  16. US 12060398

    Fibrous proteinaceous networks and methods of use thereof

    Northwestern University Β· Granted Aug 13, 2024 Β· Expires Aug 8, 2044

    granted
  17. US 12060346

    Inhibitors of APOL1 and methods of using same

    Vertex Pharmaceuticals Incorporated Β· Granted Aug 13, 2024 Β· Expires Aug 8, 2044

    granted
  18. US 12060566

    Self-inactivating lentiviral vector comprising a FOXP3 expression cassette

    The Regents of the University of California Β· Granted Aug 13, 2024 Β· Expires Aug 8, 2044

    granted
  19. US 12061206

    Diagnosis and treatment of autoimmune diseases

    Takeda Pharmaceutical Company Limited Β· Granted Aug 13, 2024 Β· Expires Aug 8, 2044

    granted
  20. US 12060555

    MicroRNA-33 inhibitors and use thereof in the treatment of pulmonary fibrosis

    UNIVERSITY OF CONNECTICUT Β· Granted Aug 13, 2024 Β· Expires Aug 8, 2044

    granted
  21. US 12059471

    Complex

    UNITED IMMUNITY, CO., LTD. Β· Granted Aug 13, 2024 Β· Expires Aug 8, 2044

    granted
  22. US 12060590

    PH20 polypeptide variants, formulations and uses thereof

    HALOZYME, INC. Β· Granted Aug 13, 2024 Β· Expires Aug 8, 2044

    granted
  23. US 12060558

    Methods and compositions for treatment of cholesteryl ester storage disease

    STOKE THERAPEUTICS, INC. Β· Granted Aug 13, 2024 Β· Expires Aug 8, 2044

    granted
  24. US 12060419

    CD79A chimeric antigen receptors

    REGENERON PHARMACEUTICALS, INC. Β· Granted Aug 13, 2024 Β· Expires Aug 8, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.